What Happened to Lobotomy Patients?

A lobotomy, also known as a leucotomy, is a form of psychosurgery developed in the 1930s that involves surgically altering the frontal lobes of the brain. The procedure entails severing nerve pathways connecting the prefrontal cortex with other brain areas. Before modern psychotropic drugs, severe mental illnesses like schizophrenia, major depression, and obsessive-compulsive disorder were often considered untreatable. Physicians sought drastic physical interventions, using the lobotomy to manage the most distressing symptoms by targeting the brain’s physical structure.

The Procedure and Its Immediate Goals

The initial technique was developed by Portuguese neurologist António Egas Moniz. It involved drilling holes into the skull to access the frontal lobes, where Moniz used a specialized instrument called a leucotome to destroy sections of white matter tissue. The goal was to reduce the intense emotional and psychological tension experienced by patients. Proponents theorized that psychiatric disorders were caused by fixed, abnormal thought patterns, which could be broken by cutting these neural connections.

American physician Walter Freeman popularized the transorbital lobotomy, a faster, more aggressive method. This technique involved driving a thin, pick-like instrument through the eye socket to reach the frontal lobe, eliminating the need for skull drilling. Freeman could perform the operation in minutes, often using only electroshock treatment for anesthesia. The intent was to quiet the patient, alleviating severe agitation, catatonia, and anxiety. Success was often measured not by the patient’s functional recovery, but by a reduction in disruptive behavior, making them easier to manage in overcrowded institutions.

Profound and Varied Long-Term Outcomes

Patients who survived the procedure faced a complex and often devastating array of long-term consequences. Outcomes varied widely, ranging from quiet compliance to profound, permanent disability. A common result was emotional flattening, where patients lost the capacity for deep feeling, experiencing neither significant joy nor despair. This reduced the emotional intensity of their original symptoms, but simultaneously stripped away the nuances of their personality.

Many patients exhibited pervasive apathy and a loss of initiative, which Freeman often described as an “infantile personality.” This reduced spontaneity and drive, coupled with impaired self-control, meant they were less agitated but also less functional. A 1967 follow-up study found that 91% of patients suffered from a distinct personality defect a decade later. Although some were able to leave the hospital, they frequently required constant supervision due to their diminished capacity to function independently.

Cognitive decline was a frequent outcome, particularly impacting executive functions. The prefrontal cortex is responsible for higher-level thought processes, including planning, abstract reasoning, and decision-making. Severing connections in this area impaired judgment and the ability to strategize, making it difficult to maintain employment or navigate complex social situations. For some, the outcome was so severe they were described as being like a “veritable household pet.”

Patients also experienced significant physical and neurological complications. The mortality rate from the surgery was substantial, with estimates ranging as high as 14% in some reports. Among survivors, neurological issues were common, including chronic headaches and epileptic seizures. One study indicated that 12% of patients developed epilepsy after the surgery.

The case of Rosemary Kennedy, sister of President John F. Kennedy, illustrates the potential damage of the lobotomy. In 1941, she underwent the procedure to treat mood swings and behavioral issues. The operation left the 23-year-old permanently incapacitated, unable to walk, and with severely limited speech. She was left with the mental capacity of a toddler and institutionalized for the rest of her life. Her outcome was an extreme example of the irreversible neurological damage resulting from the invasive nature of the brain surgery.

Ethical Collapse and Medical Abandonment

The practice of lobotomy faced increasing scrutiny as the long-term effects became apparent. Growing public and medical opposition centered on the irreversible nature of the surgery and the questionable definition of a successful outcome. Reducing a patient to docility at the expense of their personality and intellectual function was increasingly seen as mutilation and control, not a cure. The lack of patient autonomy, with decisions often made by family members or institutional doctors, fueled the ethical backlash.

A profound medical shift led directly to the procedure’s abandonment in the mid-1950s: the introduction of the first effective antipsychotic and antidepressant medications. Chlorpromazine, introduced in the early 1950s, offered a less invasive and more targeted treatment for symptoms of psychosis and agitation. Physicians suddenly had pharmacological tools that could manage severe mental illness without the immense physical and cognitive risks associated with brain surgery.

The Soviet Union was among the first nations to ban the procedure in 1950, citing a high rate of severe postoperative complications and moral implications. The practice rapidly declined across the United States and Europe shortly after pharmacotherapy was introduced. The development of modern psychotropic drugs rendered the lobotomy obsolete, relegating it to a dark period in medical history due to its destructive outcomes.